Introduction:

The diagnosis of polycystic ovary syndrome, due to its great phenotypic diversity, has been and is the subject of debate. It is in this context that in recent years the measurement of anti-Müllerian hormone has been proposed as a more effective indicator in the evaluation of follicular dysfunction.

Objective:

Compile information on the antimullerian hormone and its diagnostic utility in polycystic ovary syndrome. Methods: Bibliographic review of 57 articles obtained from the Google Scholar, Medline and Pubmed databases.

Conclusions:

The intrafollicular concentration of anti-Müllerian hormone is inversely proportional to the size of the ovarian follicle and its serum levels are proportional to the reserve of follicles in the preantral or small antral stage. An increase in anti-Müllerian hormone has been observed in women with polycystic ovary syndrome, which is believed to play a role in the pathogenesis of abnormal folliculogenesis and ovarian dysfunction. For this reason, the determination of anti-Müllerian hormone has been used for diagnostic purposes, as an indicator of follicular reserve or as a predictor of response to treatment. However, the technical difficulties for the measurement and the population and inter-individual variability have meant that its practical utility for the diagnosis of polycystic ovary syndrome has not been consistently established.

        · resumen en Español     · texto en Español     · Español ( pdf )